Arda Therapeutics
Arda Therapeutics is a San Carlos, California biotech company founded in 2021 that develops targeted cell depletion therapies for chronic disease. Rather than modulating the proteins that pathogenic cells produce, Arda uses a single-cell sequencing and computational discovery engine to map disease-specific cell states, identify surface markers on harmful cells, and design targeted biologics that selectively deplete them across fibrotic, autoimmune, and metabolic conditions. Backed by a $43M Series A led by a16z Bio + Health with GV, Two Sigma Ventures, Eli Lilly and others. This API Evangelist profile tracks the company's public developer and web surface; Arda currently publishes a corporate marketing site with no public developer API.
Arda Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Cell Depletion, and Single Cell.
Arda Therapeutics’ developer surface includes product news and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 6
The organization behind the API
Other 1
Properties that don't map to a standard resource type